IP Verse

Biogen Idec Ma Inc. opposition analysis

COMPANY ANALYSIS

Latest patents of Biogen Idec Ma Inc. opposed by its competitors

Patent:
EP2645106
Grant Date:
Oct 2, 2024
Title:
Methods And Products For Evaluating An Immune Response To A Therapeutic Agent
Oppositions:
1
Patent:
EP2701778
Grant Date:
Oct 18, 2023
Title:
A Limiter For A Dispensing Device
Oppositions:
2
Patent:
EP2653873
Grant Date:
Aug 24, 2022
Title:
Compositions And Uses For Treating Multiple Sclerosis
Oppositions:
14
Patent:
EP2870250
Grant Date:
Jun 29, 2022
Title:
Cell Line Expressing Single Chain Factor Viii Polypeptides And Uses Thereof
Oppositions:
2
Patent:
EP2676967
Grant Date:
Aug 14, 2019
Title:
Methods Of Treating Inflammatory And Autoimmune Diseases With Natalizumab
Oppositions:
1
Patent:
EP2715352
Grant Date:
Apr 24, 2019
Title:
Method Of Assessing Risk Of Pml
Oppositions:
1
Patent:
EP2483289
Grant Date:
Mar 20, 2019
Title:
Methods Of Preventing And Removing Trisulfide Bonds
Oppositions:
3
Patent:
EP2707383
Grant Date:
Apr 18, 2018
Title:
Methods Of Preventing And Removing Trisulfide Bonds
Oppositions:
2
Patent:
EP1991267
Grant Date:
Dec 20, 2017
Title:
Methods Of Treating Inflammatory And Autoimmune Diseases With Natalizumab
Oppositions:
1
Patent:
EP2524060
Grant Date:
Nov 29, 2017
Title:
Assay For Jc Virus Antibodies
Oppositions:
1

Competitors of Biogen Idec Ma Inc.

PHARMACEUTICAL WORKS POLPHARMA SA

HEXAL AG

POLPHARMA BIOLOGICS S.A.

Want to track Biogen Idec Ma Inc.?

Feel free to send us a message here and we will get back to you